,Date,Title,URL,Journal,Severe,Severe lower bound,Severe upper bound,Severe p-value,Severe Significant,Severe Adjusted,Severe Calculated,Fatality,Fatality lower bound,Fatality upper bound,Fatality p-value,Fatality Significant,Fatality Adjusted,Fatality Calculated,Multivariate adjustment,Design,Sample,Study population,Added on,Critical only,Discharged vs. death?,Sample Text,Matches,Entry
,2020-08-31,Safe bronchodilator treatment in mechanically ventilated COVID-19 patients: A single center experience,https://doi.org/10.1016/j.jcrc.2020.04.010,Journal of Critical Care,,,,,,,,,,,,,,,,Other,, 0883-9441/© 2020 Elsevier Inc. All rights reserved.,,,,,"A significant proportion of COVID-19 patients suffer from chronic obstructive lung disease, asthma or other pulmonary disorders, which are associated with an increased risk of severe infection requiring respiratory assistance .",2020-05-01
,2020-08-31,Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers,https://doi.org/10.1016/j.dsx.2020.03.016,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,187,"Methods We have systematically searched the medical database up to March 27, 2020 and retrieved all the published articles in English language related to our topic using MeSH key words.",,,,"In a study of 187 patients with COVID-19, Guo et al.","found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p ¼ 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p ¼ 0.09) for death.

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p = 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p = 0.09) for death.",2020-04-17
,2020-06-30,"Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China",https://doi.org/10.1016/j.jcv.2020.104364,Journal of Clinical Virology,,,,,,,,,,,,,,,,Retrospective observational,221,"For this retrospective, single-center study, we recruited 221 patients who were laboratory-confirmed and diagnosed as COVID-19 pneumonia according to WHO interim guidance , from January 2, 2020 to February 10, 2020 at Zhongnan Hospital of Wuhan University, Wuhan, China.",,,,"The study population included a total of 221 admitted patients with confirmed COVID-19 infection in Zhongnan Hospital of Wuhan University, between January 2, 2020 and February 10, 2020.","In total, 78 (35.3%) patients had 1 or more chronic comorbidities, including hypertension (54 [24.4%]), diabetes (22 [10.0%]), cardiovascular disease (22 [10.0%]), cerebrovascular disease (15 [6.8%]), chronic obstructive pulmonary disease (6 [2.7%]), chronic kidney disease (6 [2.7%]), chronic liver disease (7 [3.2%]), malignancy (9 [4.1%]), and patients with immunosuppression treatment (3 [1.4%]) (Table 1).",2020-05-12
,2020-06-30,Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review,https://doi.org/10.1016/j.jcv.2020.104380,Journal of Clinical Virology,,,,,,,,,,,,,,,,Systematic review,4,"A literature search was conducted on PubMed, Embase, Scopus, and Web of Science for articles published until April 9, 2020 using keywords such as ""COVID-19,"" ""tocilizumab,"" ""interleukin 6,"" or ""IL-6.""",,,,Four patients were identified that received TCZ that were diagnosed with COVID-19 [ ].,"The chronic illnesses of the patient population included hypertension, DM, stroke, and chronic obstructive pulmonary disease.",2020-05-12
,2020-05-31,Kidney disease is associated with in-hospital death of patients with COVID-19,https://doi.org/10.1016/j.kint.2020.03.005,Kidney International,,,,,,,,,,,,,,,,Prospective observational,701,"All consecutive patients with COVID-19 admitted to Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, from January 28 to February 11, 2020, were enrolled.",,,,A total of 701 patients were included in our study.,"Comorbidities include chronic kidney disease, chronic obstructive pulmonary disease, hypertension, diabetes, and tumor.

Of the total patients, 42.6% were reported as having $1 comorbidity: 2.0%, 1.9%, 33.4%, 14.3%, and 4.6% reported having, respectively, chronic kidney disease, chronic obstructive pulmonary disease, hypertension, diabetes, and tumor.",2020-04-24
,2020-05-08,Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS),https://doi.org/10.1016/j.radonc.2020.05.002,Radiotherapy and Oncology,,,,,,,,,,,,,,,,Other,4200,"Abstract The new coronavirus COVID-19 disease caused by SARS-CoV-2 was declared as global public health emergency by WHO on Jan 30, 2020.",,,,"16 The outcomes of several dozen studies indicated that approximately 4200 cases displayed remarkably rapid and marked reduction of pulmonary symptoms, with fifty percent of these patients presenting complete resolution of clinical signs and symptoms.","Individuals with comorbidities, such as diabetes, chronic renal disease, and/or chronic pulmonary disease are at greater risk of severe complications and mortality from respiratory viral infections such as COVID-19.",2020-05-12
,2020-05-08,Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia,https://doi.org/10.1016/j.bbmt.2020.04.027,Biology of Blood and Marrow Transplantation,,,,,,,,,,,,,,,,Other,52,Patients with severe aplastic anemia were identified from the database of the CIBMTR,,,,"Fifty-two patients (cases) who were transplanted with a cryopreserved graft were matched on age (≤17, 18 -39 and ≥40 years), 11, 12 donor type (HLA-matched sibling, haploidentical relative, HLA-matched or HLA-mismatched unrelated donor) 12, 13 and graft type (bone marrow or peripheral blood) 14, 15 to 195 controls from a pool of 979 patients transplanted during the same period with non-cryopreserved grafts.","The corresponding incidence of 1-year chronic GVHD was 23% (95% CI 12 -37) and 28% (95% CI 21 -35), p=0.49.",2020-05-12
,2020-05-08,Clinical characteristics of Coronavirus Disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases,https://doi.org/10.1016/j.dld.2020.04.034,Digestive and Liver Disease,,,,,,,,,,,,,,,,Case series,504,"Clinical data were extracted from the electronic medical records of 504 patients with confirmed COVID-19 patients who were treated at the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology and retrospectively analysed.",,,,"Clinical data were extracted from the electronic medical records of 504 patients with confirmed COVID-19 patients who were treated at the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology and retrospectively analysed.","Comorbidities included chronic lung disease, hypertension, coronary heart disease, diabetes, chronic kidney disease, chronic liver disease (including cirrhosis), cerebrovascular disease, and malignancy.",2020-05-12
,2020-05-06,Benchmarking the CoVID-19 pandemic across countries and states in the U.S.A. under heterogeneous testing,https://doi.org/10.1101/2020.05.01.20087882,medrxiv,,,,,,,,,,,,,,,,Other,,Data required for our estimates are readily available to public health officials through COVID-19 data repositories; data and code for our analyses are also available.,,,,Our results were robust to various model specifications.,"e Share over age 70 with a chronic respiratory disease is the share of the population with age equal or greater than 70 years old with a chronic respiratory disease, including chronic obstructive pulmonary disease and asthma.",2020-05-12
,2020-05-04,Granulocyte-targeted therapies for airway diseases,https://doi.org/10.1016/j.phrs.2020.104881,Pharmacological Research,,,,,,,,,,,,,,,,Other,III,Here we discuss the role of granulocytes in respiratory diseases and summarize therapeutic strategies focused on granulocyte recruitment and activation in the lungs.,,,,"Several Phase IIb and III clinical trials had shown the clinical efficacy of benralizumab in reducing exacerbations and controlling severe asthma , prior to its approval by the FDA in 2017 and by the EMA in 2018 for the treatment of patients with severe eosinophilic asthma.","As a result, respiratory diseases, which includes asthma, chronic obstructive pulmonary disease (COPD) and acute lower respiratory tract infections (LTRI), are a major cause of death worldwide.",2020-05-12
,2020-04-30,Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence?,https://doi.org/10.1016/j.ejim.2020.04.058,European Journal of Internal Medicine,,,,,,,,,,,,,,,,Other,12,Data were collected in a fully anonymized and pooled way using the hospital electronic chart.,,,,Twelve individuals (34.3%) underwent only one test.,"An unfavourable prognosis in old Covid-19 subjects was associated with dyspnoea, lymphocytopenia, comorbidities -including cardiovascular conditions, chronic obstructive pulmonary disease, and acute respiratory distress syndrome development .",2020-05-12
,2020-04-29,Epidemiological and clinical characteristics of the early phase of the COVID-19 epidemic in Brazil,https://doi.org/10.1101/2020.04.25.20077396,medrxiv,,,,,,,,,,,,,,,,Case series,10,"Methods: Individual-level and aggregated COVID-19 data were analysed to investigate demographic profiles, socioeconomic drivers and age-sex structure of COVID-19 tested cases.",,,,"Overall, only four newborns, three infants (6 to 8 month-old), ten children (1 to 12 years old), and twelve adolescents (12 to 17 years old) were diagnosed with COVID-19.","Most common comorbidities were heart disease, hypertension, diabetes, and chronic respiratory disease.",2020-05-12
,2020-04-28,Health Insurance Status and Risk Factors for Poor Outcomes With COVID-19 Among U.S. Health Care Workers: A Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197038/,Ann Intern Med,,,,,,,,,,,,,,,,Cross-sectional,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,,,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,"Of these highrisk persons, 275 000 (CI, 154 000 to 396 000), or 7.5% (CI, 4.2% to 10.8%), were uninsured, including 11.4% (CI, 4.6% to 18.2%) of those with diabetes and 20.8% (CI, 13.8% to 27.8%) of those with chronic lung disease other than asthma.",2020-05-12
,2020-04-28,Dataset on the COVID-19 Pandemic Situation in Tunisia with application to SIR Model,https://doi.org/10.1101/2020.04.23.20076802,medrxiv,,,,,,,,,,,,,,,,Modeling,,"The data of COVID-19 in Tunisia from March 02, 2020 to April 19, 2020 were collected from the website of three official sources: the National Observatory of New and Emerging Diseases of the Tunisian Ministry of Health , the Coronavirus Worldometer , and the World Health Organization (WHO) .",,,,"total infected cases, total deaths, and total recovery 02, 2020 to April 19, 2020.","Older people and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are at risk for severe disease and mortality.",2020-05-12
,2020-04-28,"Predictive factors for disease progression in hospitalized patients with Coronavirus Disease 2019 in Wuhan, China",https://doi.org/10.1016/j.jcv.2020.104392,Journal of Clinical Virology,,,,,,,,,,,,,,,,Retrospective observational,111,"The laboratory-confirmed patients with COVID-19 admitted to Union Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 13 to February 16 in 2020 were enrolled.",,,,A total of 111 patients were included.,"Comorbidities included hypertension, cardiovascular disease, diabetes, chronic obstructive pulmonary disease, chronic liver disease, and malignancy.",2020-05-01
,2020-04-28,Prognostic Value of Right Ventricular Longitudinal Strain in Patients with COVID-19,https://doi.org/10.1016/j.jcmg.2020.04.014,JACC: Cardiovascular Imaging,,,,,,,,,,,,,,,,Other,120,"This observational study was performed at the west branch of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology-a designated hospital to treat patients with COVID-19.",,,,Methods 120 consecutive patients with COVID-19 who underwent echocardiography examination were enrolled in our study.,Chronic obstructive pulmonary disease was found in 6 patients with COVID-19.,2020-05-12
,2020-04-27,Coronavirus disease 2019 in pregnancy,https://doi.org/10.1016/j.ijid.2020.04.065,International Journal of Infectious Diseases,,,,,,,,,,,,,,,,Retrospective observational,82,"All patients consecutively admitted in The Central Hospital of Wuhan with the diagnosis of COVID-19 between 15 January to 15 March 2020 were selected from the electronic medical records, and males were excluded.",,,,"Results Eighty-two patients (28 pregnant women, 54 reproductive-aged non-pregnant women) with laboratory confirmed COVID-19 were enrolled in this study.","No cancer, chronic respiratory disease and heart disease were reported.",2020-05-01
,2020-04-25,COVID-19 Fatality and Comorbidity Risk Factors among Confirmed Patients in Mexico,https://doi.org/10.1101/2020.04.21.20074591,medrxiv,,,,,,,,,,,,,,,,Other,7497,"In this paper we estimate fatality risks based on survival analysis methods, calculated from individual-level data on symptomatic patients confirmed with COVID-19 recently released by the Mexican Ministry of Health.",,,,"Our analysis is based on 7,497 patients who tested positive for COVID-19 in Mexico, a subset of a larger dataset of 49,167 patients with COVID-19 related symptoms who sought attention in medical units and were tested with positive, negative (29,301 cases) and pending (12,369 cases) results.","In contrast, high blood pressure increases the estimated hazard by 38% (HR=1.378, 95% CI: 1.086-1.749), immune suppression by 70% (HR=1.696, 95% CI: 1.148-2.505), diabetes by 73% (HR=1.730, 95% CI: 36.0-120.2), COPD by 77% (HR=1.770, 95% CI: 1.269-2.469), obesity by 78% (HR=1.776, 95% CI: 1.415-2.231), and chronic liver disease by 168% (HR=2.679, 95% CI: 1.789-4.014).

The data include information as well on preexisting comorbidities such as high blood pressure, diabetes, chronic obstructive pulmonary disease (COPD), asthma, immunosuppression, cardiovascular diseases, obesity, chronic kidney disease (CKD) and smoking.",2020-05-01
,2020-04-24,The clinical manifestations and management of COVID-19-related liver injury,https://doi.org/10.1016/j.jfma.2020.04.020,Journal of the Formosan Medical Association,,,,,,,,,,,,,,,,Other,148,"The first imported COVID-19 case in Taiwan was diagnosed on Jan 21, 2020.",,,,"4 In a previous study on 148 COVID-19 patients, the incidence rates of elevated liver function tests were as follows: LDH (35.1%), AST (21.6%), ALT (18.2%), GGT (17.6%), total bilirubin (6.1%) and ALP (4.1%).","cardiovascular disease, diabetes, chronic respiratory diseases, hypertension, and cancer) are at risk of a severe disease course.",2020-05-01
,2020-04-24,Co-infections: potentially lethal and unexplored in COVID-19,https://doi.org/10.1016/s2666-5247(20)30009-4,The Lancet Microbe,,,,,,,,,,,,,,,,Other,,"Zhou and colleagues 3 showed that in the current coronavirus disease 2019 (COVID-19) pandemic, 50% of patients with COVID-19 who have died had secondary bacterial infections, and Chen and colleagues 4 have recorded both bacterial and fungal co-infections.",,,,"Zhou and colleagues 3 showed that in the current coronavirus disease 2019 (COVID-19) pandemic, 50% of patients with COVID-19 who have died had secondary bacterial infections, and Chen and colleagues 4 have recorded both bacterial and fungal co-infections.","Chronic obstructive pulmonary disease (COPD) is a risk factor for severe COVID-19 disease and many patients with COPD will have underlying chronic bacterial infections before severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but this important information is not being reported.",2020-05-12
,2020-04-23,"Clinical Characteristics of 20,662 Patients with COVID-19 in mainland China: A Systemic Review and Meta-analysis",https://doi.org/10.1101/2020.04.18.20070565,medrxiv,,,,,,,,,,,,,,,,Systematic review,20662,"We searched the PubMed, Embase, Scopus, Web of Science, Cochrane Library, bioRxiv, medRxiv, and SSRN databases for studies related to COVID-19 published or preprinted in English or Chinese from January 1 to March 15, 2020.",,,,"A total of 20,662 patients with COVID-19 were included.","Of 8028 patients with COVID-19, 3066 (38.52%, 95%CI 34.17-43.42%) had at least one comorbidity, including hypertension (20.78%), diabetes (12.04%), cardiovascular disease (8.58%), cerebrovascular diseases (6.01%), chronic obstructive pulmonary disease (4.20%), chronic liver disease (4.19%), malignancy (3.92%), and chronic renal disease (3.11%).",2020-05-01
,2020-04-23,Influence of blood pressure on pneumonia risk: Epidemiological association and Mendelian randomisation in the UK Biobank,https://doi.org/10.1101/2020.04.19.20071936,medrxiv,,,,,,,,,,,,,,,,Other,4,and accounting for skewness in the phenotypic data identified using the Robustbase package in 10 R (setting range=3) (,,,,Epidemiologic analyses have correlated hypertension with pneumonia risk in small 4 studies 2 3 .,"Prevalent hypertension at baseline was significantly associated with increased risk for incident respiratory disease including pneumonia (hazard ratio 1.36 (95% confidence interval 1.29 to 1.43), P<0.001), acute respiratory distress syndrome or respiratory failure (1.43 (1.29 to 1.59), P<0.001), and chronic lower respiratory disease (1.30 (1.25 to 1.36), P<0.001), independent of age, age2, sex, smoking status, BMI, prevalent diabetes mellitus, prevalent coronary artery disease, and principal components of ancestry.",2020-05-01
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,,,,,,,,,,,,,,,,Systematic review,1063,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.",,,,"Our search retrieved 1,063 publications, of which 175 were duplicates.","There was a higher likelihood that patients with severe disease had hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory disease (OR 2.46, 95% CI: 1.76-3.44), or cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22), compared with patients with non-severe disease.

The most common comorbidities were hypertension (17±7, 95% CI 14-22%), diabetes (8±6, 95% CI 6-11%), cardiovascular diseases (5±4, 95% CI 4-7%) and respiratory system diseases (2±0, 95% CI 1-3%).

The most common clinical symptoms were fever (91±3%, 95% CI 86-97%), cough (67±7%, 95% CI 59-76%), fatigue (51±0%, 95% CI 34-68%) and dyspnea (30±4%, 95% CI 21-40%).",2020-05-01
,2020-04-21,Potential Threats of COVID-19 On Quarantined Families,https://doi.org/10.1016/j.puhe.2020.04.014,Public Health,,,,,,,,,,,,,,,,Other,,,,,,,"The most common and serious diseases associated with poor indoor air quality include, acute lower respiratory infections (ALRI), chronic obstructive pulmonary disease (COPD), Lung cancer, cardiovascular disease, and asthma.",2020-04-24
,2020-04-20,An Atypical Presentation of Novel Coronavirus Disease 2019 (COVID-19),https://doi.org/10.1016/j.amjmed.2020.03.026,The American Journal of Medicine,,,,,,,,,,,,,,,,Other,1,1 Some patients have experienced gastrointestinal symptoms such as diarrhea and nausea.,,,,1 Some patients have experienced gastrointestinal symptoms such as diarrhea and nausea.,"Hypertension, heart disease, and chronic lung disease are risk factors for severe disease.",2020-05-12
,2020-04-16,Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis,https://doi.org/10.1101/2020.04.12.20062869,medrxiv,,,,,,,,,,,,,,,,Systematic review,3473,"Searched Databases included PubMed, Embase, Scopus, Web of Science, Cochrane Library, medRxiv pre-print database as well as Science Direct search engine.",,,,Results: Sixteen papers including 3473 patients entered into meta-analysis for ICU admission and mortality outcome and fifty-nine papers including 9509 patients for descriptive outcomes.,"Results of meta-analysis indicated that acute cardiac injury, (OR: 15.94, 95% CI 2.31-110.14), hypertension (OR: 1.92, 95% CI 1.92-2.74), heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.

Results of meta-analysis indicated that acute cardiac injury (OR: 15.94, 95% CI 2.31-110.14), Hypertension (OR: 1.92, 95% CI 1.92-2.74), Heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.",2020-04-24
,2020-04-16,Renin-angiotensin system at the heart of COVID-19 pandemic,https://doi.org/10.1016/j.biochi.2020.04.008,Biochimie,,,,,,,,,,,,,,,,Other,,"It has been pointed out that in patients with severe form of COVID-19 disease, comorbidities are frequent.",,,,"It has been pointed out that in patients with severe form of COVID-19 disease, comorbidities are frequent.","Individuals at highest risk for severe disease and death were those aged over 60 years, and with underlying illnesses including hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer.",2020-04-24
,2020-04-15,"Clinical characteristics of 34 COVID-19 patients admitted to ICU in Hangzhou, China",https://doi.org/10.1101/2020.04.12.20062604,medrxiv,,,,,,,,,,,,,,,,Case series,34,"Methods: We tracked the data until March 5, 2020.",,,,Results: 34 cases were included in the study.,"24 (70.6%) patients had chronic diseases, including hypertension (64.7%), diabetes (23.5%), cardiovascular disease (11.8%), chronic obstructive pulmonary disease (5.9%), chronic liver disease (11.8%), chronic kidney disease (5.9%).",2020-04-24
,2020-04-14,"Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor",https://doi.org/10.1016/j.phrs.2020.104833,Pharmacol Res,,,,,,,,,,,,,,,,Retrospective observational,41,"Rectal swabs, stool, urine, and saliva sampled from some COVID-19 patients were positive for the SARS-CoV-2 virus .",,,,"According to a retrospective study published in the Lancet that included 41 COVID-19 patients, 12 % developed acute cardiac injury, 80 % of these cases were diagnosed as severe cases .","It has been found that patients with coexisting disorders, including chronic obstructive pulmonary disease (COPD), hypertension, coronary heart disease, chronic kidney disease or diabetes were significantly more severe than patients without any existing disorders (Table 1 ) .",2020-05-12
,2020-04-10,The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis,https://doi.org/10.1101/2020.04.08.20057539,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,30,"DESIGN, SETTING, AND PARTICIPANTS Multicenter, retrospective cohort study of 564 consecutively hospitalized patients with confirmed COVID-19 at Third Xiangya Hospital of Central South University, Changsha Public Health Treatment Center, First Hospital of Yueyang, Junshan People's Hospital of Yueyang, Central Hospital of Shaoyang, Central Hospital of Xiangtan, Second Hospital of Changde, Central Hospital of Loudi, and First Affiliated Hospital of University of South China in Hunan province from January 17, 2020 to February 28, 2020; The final date of follow-up was March 15, 2020.",,,,"Thirty patients were classified with severe pneumonia on admission and were excluded, to leave 534 patients with non-severe COVID-19 on admission for further analysis.",Characteristics Chronic renal disease ACEI/ARB (n = 16) 1 (6.3%) Non-ACEI/ARB (n = 49) 1 (2.0%) Difference (95% CI) -4.2 (-26.4 to 5.9) P 0.435,2020-04-17
,2020-04-08,The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184394/,Cardiovasc Res,,,,,,,,,,,,,,,,Other,99,"15, 22, 23 In 2019, a novel coronavirus (SARS-CoV-2) was identified in China and all over the world.",,,,"37 In another retrospective study of 99 patients with pneumonia, 40% had CV and cerebrovascular diseases.","In MERS-CoV patients, the prevalence of chronic heart disease and hypertension is 15% and 33%, respectively.",2020-05-12
,2020-04-08,Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185114/,Aging (Albany NY),,,,,,,,,,,,,,,,Systematic review,1558,"A literature search was performed using the electronic platforms (PubMed, Cochrane Library, Embase, and other databases) to obtain relevant research studies published up to March 1, 2020.",,,,A total of 1558 patients with COVID-19 in 6 studies were enrolled in our meta-analysis eventually.,"Inclusion criteria are as follows: Types of Studies: published studies reported the relationship between comorbidity and patients with COVID-19; Subjects: diagnosed patients with COVID-19; Exposure intervention: COVID-19 patients with comorbidity included: hypertension, diabetes, chronic obstructive pulmonary disease (COPD), liver disease, malignancy, renal disease, cardiovascular disease, cerebrovascular disease; Outcome indicator: the odds ratios (OR) with 95% confidence intervals (CI) for each comorbidity.

Hypertension (OR: 2.29, P<0.001), diabetes (OR: 2.47, P<0.001), chronic obstructive pulmonary disease (COPD) (OR: 5.97, P<0.001), cardiovascular disease (OR: 2.93, P<0.001), and cerebrovascular disease (OR:3.89, P=0.002)were independent risk factors associated with COVID-19 patients.

The results find that COVID-19 patients with hypertension (OR: 2.29, 95% CI: 1.69-3.10, P<0.001) (Figure 2A), diabetes (OR: 2.47, 95% CI: 1.67-3.66, P<0.001) (Figure 2B), or COPD (OR: 5.97, 95% CI: 2.49-14.29, P<0.001) (Figure 2C) had a higher risk of exacerbation.",2020-05-12
,2020-04-08,Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters,https://doi.org/10.1101/2020.04.05.20054361,medrxiv,,,,,,,,,,,,,,,,Other,,We could retrieve data from 6 locations on the COVID-19 mortality of people who were both <65 years old and had no underlying diseases.,,,,"Information was extracted independently in duplicate by two authors (JI, CA) and discrepancies were resolved.","Predisposing conditions for worse outcome in COVID-19 may include 8-10 cardiovascular disease, hypertension, diabetes, chronic obstructive pulmonary disease and severe asthma, kidney failure, severe liver disease, immunodeficiency, and malignancy.",2020-05-12
,2020-04-06,Case fatality rate in COVID-19: a systematic review and meta-analysis,https://doi.org/10.1101/2020.04.01.20050476,medrxiv,,,,,,,,,,,,,,,,Systematic review,29,"PubMed, Scopus and Web of Science were searched using pre-specified keywords on March 07, 2020.",,,,"Results: The meta-analysis included 29 studies representing 2,090 individuals.","12 Proportions of the following variables within a study sample were extracted: age < 18 120 years, age > 60 years, female sex, diabetes mellitus, hypertension, heart disease, chronic liver 121 disease, chronic kidney disease, chronic obstructive pulmonary disease, malignancy, 122 immunosuppression (e.g.",2020-04-10
,2020-03-30,Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up,https://doi.org/10.1016/j.jinf.2020.03.019,Journal of Infection,,,,,,,,,,,,,,,,Retrospective observational,339,"Methods Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included.",,,,"Results 339 patients with COVID-19 (aged 71±8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases.","Dyspnea, lymphocytopenia, comorbidities including cardiovascular disease and chronic obstructive pulmonary disease, and acute respiratory distress syndrome were predictive of poor outcome.

Patient history were collected for comorbidities including hypertension, diabetes, cardiovascular disease, cerebrovascular disease, chronic kidney disease, chronic liver disease, chronic obstructive pulmonary disease (COPD), malignancy and autoimmune diseases.

Symptoms of dyspnea (HR 2.35, CI 1.43-3.87, P = 0.001) and comorbidities including cardiovascular disease (HR 2.87, CI 1.70-4.83, P < 0.001), cerebrovascular disease (HR 3.26, CI 1.66-6.40, P = 0.001) and COPD (HR 3.72, CI 1.94-7.13, P < 0.001) were all predictive of fatal outcomes.

Symptoms of dyspnea (HR 2.35, P = 0.001), comorbidities including cardiovascular disease (HR 1.86, P = 0.031) and chronic obstructive pulmonary disease (HR 2.24, P = 0.023), and acute respiratory distress syndrome (HR 29.33, P < 0.001) were strong predictors of death.",2020-04-17
,2020-03-27,ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19,https://doi.org/10.1101/2020.03.21.20040261,medrxiv,,,,,,,,,,,,,,,,Other,700,Redundant terms were collapsed using fuzzy string matching.,,,,"Here, we analyzed over 700 lung transcriptome samples of patients with comorbidities associated with severe COVID-19 and found that ACE2 was highly expressed in these patients, compared to control individuals.","Patients who died from Coronavirus disease 2019 (COVID-19) often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease.",2020-04-03
,2020-03-26,"COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis",https://doi.org/10.1101/2020.03.24.20042903,medrxiv,,,,,,,,,,,,,,,,Systematic review,4789,"Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020.",,,,A total of 4789 patients with a mean age of 49 years were evaluated.,"The most common comorbidities were respectively hypertension (18.5 %, CI 12.7-24.4), 246 cardiovascular diseases (14.9 %, CI 6.0-23.8), diabetes (10.8 %, CI 8.3-13.3), chronic liver 247 disease (8.1, CI 4.6-11.6) and smoking (8.0%, CI 2.3-13.6) ( Table 3) .

The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8).

The most prevalent comorbidities in our study were hypertension (18.5 %, CI 12.7-24.4) followed 307 by cardiovascular diseases (14.9 %, CI 6.0-23.8) and diabetes (10.8 %, CI 8.3-13.3).",2020-04-03
,2020-03-26,SARS-CoV-2 Infection in Pregnancy – a Review of the Current Literature and Possible Impact on Maternal and Neonatal Outcome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174004/,Geburtshilfe Frauenheilkd,,,,,,,,,,,,,,,,Case series,3," The first study (“Wuhan patient population”) 34 comprises nine cases which presented between 20th January 2020 and 31st January 2020, inclusively, at the Zhongnan Hospital of Wuhan University.",,,,Three patients died after delivery.,"Severe clinical courses may arise in immunocompromised patients and patients with underlying conditions such as chronic lung diseases, diabetes or chronic kidney disease 29 and are associated with the development of pneumonia and transition to acute respiratory distress syndrome.",2020-05-01
,2020-03-24,Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19),https://doi.org/10.1016/j.rmed.2020.105941,Respiratory Medicine,,,,,,,,,,,,,,,,Systematic review,7,"An electronic search was performed in Medline (PubMed interface), Scopus and Web of Science, using the keywords ""chronic obstructive pulmonary disease"" OR ""COPD"" OR ""clinical characteristics"" AND ""coronavirus 2019"" OR ""COVID-19"" OR ""2019-nCoV"" OR ""SARS-CoV-2"", between 2019 and present time (i.e., March 9, 2020).",,,,"Thus, a total number of 7 studies were finally included in our meta-analysis, totaling 1592 COVID-19 patients, 314 of which (19.7%) had severe disease",Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19),2020-04-03
,2020-03-24,Telemedicine in the Era of COVID-19,https://doi.org/10.1016/j.jaip.2020.03.008,The Journal of Allergy and Clinical Immunology: In Practice,,,,,,,,,,,,,,,,Other,,,,,,,"COVID-19 is a respiratory virus, which means that patients who are at increased risk of morbidity include our patients with asthma, chronic obstructive pulmonary disease, and also with immunodeficiency.",2020-03-27
,2020-03-24,"Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133387/,Gut,,,,,,,,,,,,,,,,Modeling,651,DESIGN: COVID-19 hospital patients were admitted in the Zhejiang province from 17 January 2020 to 8 February 2020.,,,,"This study enrolled 651 patients with confirmed COVID-19 from 17 January 2020 to 8 February 2020 in Zhejiang province, among which 74 (11.4%) patients presented with at least one GI tract symptom (nausea, vomiting and diarrhoea), which was higher than previous Wuhan data (table 1) .","There were no coexisting conditions of cancer, chronic renal disease, pregnancy, chronic obstructive pulmonary disease or immunosuppression.",2020-04-10
,2020-03-20,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.17.20037572,medrxiv,,,,,,,,,,,,,,,,Systematic review,30,"Methods: The PubMed, Web of Science Core Collection, Embase, Cochrane and MedRxiv databases were searched through February 25, 2020.",,,,"Results: A total of 30 studies including 53000 patients with COVID-19 were included in this study, the mean age was 49.8 years (95% CI, 47.5-52.2 yrs) and 55.5% were male.","The predictor for disease severity included old age (≥ 50 yrs, odds ratio [OR] = 2.61; 95% CI, 2.29-2.98), male (OR =1.348, 95% CI, 1.195-1.521), smoking (OR =1.734, 95% CI, 1.146-2.626) and any comorbidity (OR = 2.635, 95% CI, 2.098-3.309), especially chronic kidney disease (CKD, OR = 6.017; 95% CI, 2.192-16.514), chronic obstructive pulmonary disease (COPD, OR = 5.323; 95% CI, 2.613-10.847) and cerebrovascular disease (OR = 3.219; 95% CI, 1.486-6.972).

Comorbidities with pooled OR larger than 2 included CKD (6.02; 95% CI, 2.19-16.51; n = 4; I 2 = 0), COPD (5.32; 95% CI, ; n = 6; I 2 = 0%), cerebrovascular diseases (3.19 ; 95% CI, 1.51-6.77; n = 6; I 2 = 0%), tumor (3.21; 95% CI, ; n = 4; I 2 = 30%), diabetes (2.49; 95% CI, ; n = 10; I 2 = 44%) and hypertension (2.06; 95% CI, 1.61-2.62; n = 10; I 2 = 36%) ( Figure 4 , eFigure 5).

Moreover, hypertension, diabetes, CVD, cerebrovascular diseases, chronic obstructive pulmonary disease (COPD) and chronic kidney disease (CKD) were significantly more common in severe cases as compared with non-severe cases (all for P < 0.05).

The most common comorbidities were hypertension (19.0%, 95% CI, 13.2-24.9%), followed by diabetes (8.2%, 95% CI, 6.3-10.0%) and cardiovascular diseases (CVD, 2.7%, 95% CI, 1.4-4.1%).

Fever (79.1%; 95% CI, 68.0-90.3%), cough (58.0%; 95% CI, 42.0-74.0%) and fatigue (29.3%; 95% CI, 23.

comorbidity (OR = 2.635; 95% CI, 2.098-3.309; n = 7; I 2 = 12%).",2020-03-27
,2020-03-12,Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis,https://doi.org/10.1016/j.ijid.2020.03.017,Int J Infect Dis,,,,,,,,,,,,,,,,Systematic review,576,"A systematic search was conducted on studies published from January 1, 2019 to February 25, 2020 in PubMed, EMBASE, and Web of Science databases.",,,,"As of February 25, 2020, a total of 1 576 participants were included in our meta-analysis.","The most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

Higher risk of hypertension (OR 2.36, 95% CI: 1.46–3.83), respiratory system disease (OR 2.46, 95% CI: 1.76–3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88–6.22) were observed in the severe group.

Higher risk of hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory system disease (OR 2.46, 95% CI: 1.76-3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22) were observed in the severe group.

When compared between severe and non-severe patients, the pooled OR of hypertension, respiratory system disease, and cardiovascular disease were 2.36 (95% CI: 1.46–3.83), 2.46 (95% CI: 1.76–3.44) and 3.42 (95% CI: 1.88–6.22) respectively.

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0-27.2%) and diabetes (9.7%, 95% CI: 7.2-12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8-13.8%) and respiratory system disease (1.5%, 95% CI: 0.9-2.1%).",2020-05-12
,2020-03-04,Middle East respiratory syndrome,https://doi.org/10.1016/s0140-6736(19)33221-0,Lancet,,,,,,,,,,,,,,,,Other,13," We searched publications in the English language literature on PubMed and Google Scholar (dates we used to refine our search: Sept 1, 2012, to Dec 31, 2019).",,,,"In the 2015 Korean outbreak, three of 13 patients with MERS with respiratory failure were given four infusions of convalescent plasma.107 Two of three showed neutralising activity.","MERS-CoV causes more severe disease in people older than 60 years, and those with chronic comorbid diseases such as renal disease, cancer, chronic lung disease, immunosuppression, and diabetes.

Immunocompromised patients or patients with chronic heart, liver, and kidney disease can present with atypical features, such as a longer incubation period, a longer period from initial PCR positivity to symptom onset, persistent prolonged viral shedding, and increased mortality.64, 65, 66, 67, 68, 69, 70 MERS-CoV causes more severe disease in people older than 60 years, and those with chronic comorbid diseases such as renal disease, cancer, chronic lung disease, immunosuppression, and diabetes.",2020-05-12
,2020-02-28,Anesthetic Management of Patients with COVID 19 Infections during Emergency Procedures,https://doi.org/10.1053/j.jvca.2020.02.039,J Cardiothorac Vasc Anesth,,,,,,,,,,,,,,,,Retrospective observational,30,"For this retrospective, multicenter clinical study, patients with confirmed or suspected COVID 19 from January 23 to 31, 2020, at the Wuhan Union Hospital, the Wuhan Children's Hospital, The Central Hospital of Wuhan, and the Wuhan Fourth Hospital in Wuhan, China, were recruited.",,,,"According to chest x­ray and CT findings, abnormalities in chest images were detected in 30 (81%) patients.","10 (27%) patients had chronic medical illnesses, including 4 (11%) with diabetes, 8 (22%) with hypertension, and 8 (22%) with digestive system disease.

10 (27%) patients had chronic medical illnesses, including 4 (11%) with diabetes, 8 (22%) with hypertension, 8 (22%) with digestive system disease, 3 (8%) with nervous system disease, and 8 (22%) with respiratory system disease (Table 1) .

10 (27%) patients had chronic medical illnesses, including 4 (11%) with diabetes, 8 (22%) with hypertension, 8 (22%) with digestive system disease, 3 (8%) with nervous system disease, and 8 (22%) with respiratory system disease (Table 1 ).",2020-04-10
,2020-02-27,Clinical characteristics of 82 death cases with COVID-19,https://doi.org/10.1101/2020.02.26.20028191,medrxiv,,,,,,,,,,,,,,,,Case series,1334,"We retrospectively collected epidemiological and clinical features of laboratory-confirmed COVID-19 dead patients from January 11, 2020 to February 10, 2020 in the Renmin Hospital, Wuhan University.",,,,"From January 11, 2020 to February 10, 2020, a total of 1,334 patients with a diagnosis of laboratory-confirmed COVID-19 were recorded in the Renmin Hospital, Wuhan University, while 6.2% (82/1334) of patients with this disease were dead.","Age, years Chronic obstructive pulmonary disease 72.5 (65.0-80.0) 12/82 (14.6)",2020-03-27
,2020-02-21,"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",https://doi.org/10.1016/s0140-6736(20)30211-7,The Lancet,,,,,,,,,,,,,,,,Retrospective observational,99,"Methods In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020.",,,,"99 patients with 2019nCoV were included in this study, two of whom were husband and wife.",50 (51%) patients had chronic diseases.,2020-03-27
,2020-02-05,Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV,https://doi.org/10.1101/2020.02.03.20020206,medrxiv,,,,,,,,,,,,,,,,Other,6,"Six independent studies (GSE37758, GSE73395, GSE89809, GSE63127, GSE97010, and GSE14700), covering healthy volunteers, COPD patients, asthma patients, smoking individuals were collected from GEO data repository ( The samples consist of lung tissues, bronchoalveolar lavage, bronchial epithelial cells, small airway epithelial cells, and SARS infected cells.",,,,"Six independent studies (GSE37758, GSE73395, GSE89809, GSE63127, GSE97010, and GSE14700), covering healthy volunteers, COPD patients, asthma patients, smoking individuals were collected from GEO data repository ( The samples consist of lung tissues, bronchoalveolar lavage, bronchial epithelial cells, small airway epithelial cells, and SARS infected cells.","Among the 2019-nCoV infected patients, there are many patients with underlying diseases, such as chronic respiratory disease and cardiovascular disease.

The expression level of ACE2 was not significantly altered between healthy populations and patients with chronic respiratory diseases including chronic obstructive pulmonary diseases (COPD) and asthma ( Figure 1A , 1B, and 1C, p-value > 0.05).",2020-03-27
0,2020-04-27,Estimating Survival of Hospitalized COVID-19 Patients from Admission Information,http://doi.org/10.1101/2020.04.22.20075416,medrxiv,,,,,,,,OR 1.19,0.98,1.44,0.08,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,5233,"Northwell Health acute care hospitals on or after March 1, 2020, and were discharged or died before April 12, 2020. Clinical outcomes (i.e., discharges, mortality, and length of stay) were monitored until April 12, 2020, the final date of follow-up",5/6/2020,N,Y,,,
1,2020-04-25,Association between rRT-PCR test results upon admission and outcome in hospitalized chest CT-Positive COVID-19 patients; a provincial retrospective cohort with active follow-up,10.1101/2020.04.21.20074641,medrxiv,,,,,,,,OR 1.28,0.43,3.79,0.44,Not Significant,Adjusted,Extracted,"Age, ICU admission, PCR test results, admission week, number of comorbidities, cardiovascular disease, gender, diabetes, chronic kidney disease, immunodeficiency, hypertension",Retrospective observational study,1197,"Qazvin province hospitals Feb 20-March 11, 2020",5/6/2020,N,N,,,
2,2020-04-23,Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis,https://doi.org/10.1016/j.jinf.2020.04.021,Journal of Infection,OR: 5.15,2.51,10.57,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,3027 patients from 13 studies,China,5/6/2020,Y,N,,,
3,2020-04-21,Epidemiological Characteristics of Coronavirus Disease 2019 (COVID-19) Patients in IRAN: A single Center Study [Journal of Clinical Virology],https://doi.org/10.1016/j.jcv.2020.104378,Journal of Clinical Virology,,,,,,,,OR 2.05,1.0,4.22,0.05,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,2968,"Baqiyatallah hospital from 19 February 2020, to 15 April 2020",5/6/2020,N,N,,,
4,2020-04-20,"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study",http://doi.org/10.1101/2020.04.15.20067157,medRxiv,,,,,,,,HR 3.45,2.0,5.97,,Significant,Not Adjusted,Extracted,,Prospective observational study,257,"Columbia University Irving Medical Center (2 affiliated hospitals in Manhattan) from March 2nd to April 1st, 2020.",5/6/2020,N,N,,,
5,2020-04-19,Early prediction of mortality risk among severe COVID-19 patients using machine learning,https://doi.org/10.1101/2020.04.13.20064329,medRxiv,,,,,,,,OR 3.76,1.23,11.52,0.02,Significant,Not Adjusted,Calculated,,Retrospective observational study,256,"Severe COVID-19 patients only from Sino-French New City Branch of Tongji Hospital from Jan 28 to March 11, 2020",5/6/2020,N,N,,,
6,2020-04-03,History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study,https://doi.org/10.1101/2020.03.23.20041848,medRxiv,,,,,,,,HR 1.1,0.4,2.5,0.55,Not Significant,Not Adjusted,Extracted,,Retrospective observational study,275,"mainland China outside of Hubei Province, from December 18th, 2019 to March 8, 2024",4/10/2020,N,N,,,
7,2020-04-03,"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020 [MMWR Morb Mortal Wkly Rep]",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119513/,Morbidity and Mortality Weekly Report,OR 3.18,2.53,4.0,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,7162,"CDC passive surveillance registry as of March 28, 2023",5/6/2020,Y,N,,,
8,2020-04-02,"Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort",10.1016/j.jinf.2020.04.020,Journal of Infection,,,,,,,,OR 0.86,0.29,2.5,0.78,Not Significant,Not Adjusted,Calculated,,Retrospective observational study,95,"North Bristol NHS Trust March 10 to March 30, 2020",5/6/2020,N,N,,,
9,2020-03-23,Prognostic value of C-reactive protein in patients with COVID-19,https://doi.org/10.1101/2020.03.21.20040360,medRxiv,,,,,,,,OR: 3.74,1.57,8.89,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,298,"Eastern Campus of Renmin Hospital of Wuhan University from Jan 30 to Feb 20, 2027",4/10/2020,N,Y,,,
10,2020-03-23,"Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China",https://doi.org/10.1101/2020.03.19.20033175,medRxiv,,,,,,,,OR 5.44,2.45,12.06,<0.01,Significant,Not Adjusted,Calculated,,Retrospective observational study,403,"Eastern Campus of Renmin Hospital, Wuhan University from Jan 30 to Feb 25, 2020",5/6/2020,N,Y,,,
11,2020-03-06,"Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study",https://doi.org/10.1101/2020.03.03.20030353,medRxiv,OR 5.24,1.46,18.86,0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,291,"First Hospital of Changsha and Loudi Central Hospital from January 23 to February 14, 2020, followed up to Feb 20, 2020",5/6/2020,N,N,,,
12,2020-03-06,"Epidemiological and clinical features of 291 cases with coronavirus disease 2019 in areas adjacent to Hubei, China: a double-center observational study [medrxiv]",https://doi.org/10.1101/2020.03.03.20030353,medRxiv,OR 5.24,1.46,18.9,0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,291,"First Hospital of Changsha and Loudi Central Hospital from January 23 to February 14, 2020, followed up to Feb 20, 2022",5/6/2020,N,N,,,
13,2020-02-12,Caution on Kidney Dysfunctions of COVID-19 Patients,http://doi.org/10.1101/2020.02.08.20021212,,OR 4.18,1.79,9.78,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,193,"Wuhan Tongji hospital, Wuhan Pulmonary Hospital, Huangshi Central Hospital and Chongqing Southwest Hospital from January 6 to February 21, 2020",5/6/2020,N,N,,,
